The cost burden of metastatic prostate cancer in the US populations covered by employer‐sponsored health insurance is a research paper published in Cancer (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Centers for Disease Control and Prevention
Grant: SIP19‐009
FWCI
1.83
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords